During the past decade, Klinikum Konstanz conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 2 clinical trials were completed, i.e. on average, 18.2% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Klinikum Konstanz" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany" with 2 trials sponsored, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 2 trials sponsored, "AGO Research GmbH" with 1 trials sponsored and "Arcagy Research" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Konstanz" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator and "Belgian Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Konstanz" are "Idiopathic Pulmonary Fibrosis" (2 trials), "Atrial Fibrillation" (1 trials), "Brain and Central Nervous System Tumors" (1 trials), "Cardiovascular Diseases" (1 trials) and "Clinical Alarms" (1 trials). Many other conditions were trialed in "Klinikum Konstanz" in a lesser frequency.

Most popular intervention types in "Klinikum Konstanz" are "Drug" (10 trials), "Procedure" (6 trials), "Device" (4 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "radiation therapy" (3 trials), "BI 1015550" (2 trials), "Bevacizumab" (2 trials) and "conventional surgery" (2 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Konstanz" are 14 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Konstanz". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Klinikum Konstanz, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Konstanz, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".